Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Managing Atopic Dermatitis in Children

Description

The presentation focuses on managing atopic dermatitis in children, emphasizing a multifaceted approach to treatment. The speaker uses the "eczema diamond" framework, which incorporates barrier dysfunction, inflammation, pruritus, and infection to guide management strategies. Daily bathing and immediate moisturizing after bathing are critical to maintaining skin barrier integrity, while aggressive treatment of inflammation is necessary, particularly in infants. The speaker expresses caution in using systemic treatments like dupilumab in young children and discusses the importance of effective topical steroid use to control inflammation without overprescribing. Infection management is addressed, noting that while antibiotic therapy may not directly improve dermatitis, it is often necessary in the presence of infection. Antihistamines are discussed for pruritus, with the recommendation to focus on controlling inflammation first. A link between disrupted skin barriers and food sensitization is clarified, suggesting that addressing atopic dermatitis may reduce food allergy incidence. The presentation also covers cases of older children and teens, stressing the increased likelihood of recommending dupilumab in this demographic. Adverse effects of treatments, especially dupilumab, are reviewed, along with strategies for managing treatment failures and alternative therapies. The speaker advocates for thorough evaluation when responses to treatment are inadequate, including considering contact dermatitis and ensuring optimal drug dosing.

View more

Conclusions

  • Aggressive treatment of atopic dermatitis leads to better control and outcomes in young children.
  • Daily bathing and immediate moisturization are crucial in managing barrier dysfunction in atopic dermatitis.
  • Parents should be educated about the appropriate use of topical steroids to mitigate steroid phobia.
  • Infections, particularly staph infections, are common in children with atopic dermatitis and need to be managed effectively.
  • Antihistamines provide limited relief for pruritus associated with atopic dermatitis and are generally not effective unless there are other allergic conditions present.
  • Food allergies may correlate with atopic dermatitis but treatment of eczema can lead to reduced incidence of certain food allergies, like chicken egg allergy.
  • Dupilumab is an effective treatment for atopic dermatitis but can have adverse effects such as conjunctivitis and facial erythema.
  • Treatment failure of dupilumab can occur due to primary or secondary factors and requires reevaluation and possible adjustment of therapy.
  • Alternative therapies like methotrexate may be beneficial for patients not adequately responding to dupilumab.
  • Chiang C, Eichenfield LF. Quantitative assessment of combination bathing and moisturizing regimens on skin hydration in atopic dermatitis. Pediatr Dermatol. 2009.
  • Francis NA et al. Oral and topical antibiotics for clinically infected eczema in children: a pragmatic randomized controlled trial in ambulatory care. Ann Fam Med 2017.
  • Pagliaro et al, Bathing in Atopic Dermatitis in Pediatric Age: Why, How and When, Pediatr Rep 2004.
  • Sidbury et al. Guidelines of care for the management of atopic dermatitis. JAAD, 2014.
  • Yamamoto-Hanada K et al. Enhanced early skin treatment for atopic dermatitis in infants reduces food allergy. J Allergy Clin Immunol 2003.
  • McKenzie PL et al, Experience using dupilumab for pediatric atopic dermatitis at a tertiary care center: Inadequate response and adverse events. Pediatr Dermatol 2021.
  • Gori N et al, Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy. Dermatology 2021.